Race independently predicts XXXX testing frequency following a @entity263 diagnosis.

@entity1 @entity263 @entity1486
BACKGROUND: The goals of the current study were to describe patterns of @entity1486 ( @entity1486 ) surveillance for @entity263 progression in a community-based cohort of @entity1 and to identify independent clinical and sociodemographic factors that predict the frequency of surveillance. METHODS: @entity1 diagnosed with @entity263 from October 1, 1991 to December 31, 1992 in New Haven and Hartford, Connecticut, were identified. Data were collected through standardized outpatient medical record review. Multivariate statistical methods were used to determine the factors that independently predicted the frequency of surveillance. RESULTS: Six hundred fifty-eight @entity1 with @entity263 were included in the cohort. Forty-five percent of all @entity1 were tested at least once annually, and 69% were tested at least once every 2 years. Multivariate models indicated that African American @entity1 were half as likely as Caucasian @entity1 to receive annual testing (odds ratio [OR], 0.49; 95% confidence interval [CI], 0.24-0.97). @entity1 diagnosed at age 70 years or older were 38% less likely to have annual testing than @entity1 diagnosed between the ages of 65 and 69 (OR, 0.62; 95% CI, 0.41-0.94). A higher Gleason score and @entity1486 at presentation also were associated independently with higher rates of annual @entity1486 surveillance. CONCLUSIONS: Postdiagnosis @entity1486 surveillance is common, although not universal. African American @entity1 were at significantly greater risk for receiving less frequent testing compared with Caucasian @entity1 . This disparity in access to care may explain, in part, previously observed racial differences in survival in @entity263 . Further research is needed to identify the reasons for the racial disparity in @entity1486 surveillance and to design interventions to lessen these differences.
